Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheja

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Rheumatology|November 3, 2011
Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factorR Hesselstrand, A Scheja, D M Wuttge
Scandinavian Journal of Rheumatology|January 1, 1992
Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosisA Scheja, A Akesson, K Hørslev-Petersen
Scandinavian Journal of Rheumatology|December 20, 2007
Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experienceM Wildt, R Hesselstrand, A Akesson, et al.
Annals of the Rheumatic Diseases|June 15, 2004
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosisA Akesson, R Hesselstrand, A Scheja, et al.
Rheumatology (Oxford, England)|December 14, 2007
High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early diseaseR Hesselstrand, A Scheja, M Wildt, et al.
Acta Dermato-Venereologica|March 1, 1996
Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosisJ Wallengren, A Akesson, A Scheja, et al.
Clinical and Experimental Rheumatology|May 26, 1999
Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysisM Wildt, R Hesselstrand, A Scheja, et al.
Clinical and Experimental Rheumatology|January 1, 1985
Inhibition of in vivo leucocyte migration by NSAIDsA Scheja, A Forsgren, L Marsal, et al.
Scandinavian Journal of Rheumatology|September 23, 2011
Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestationsA Scheja, M Wildt, D M Wuttge, et al.
British Journal of Rheumatology|January 1, 1993
Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse diseaseA Scheja, G Hellmer, F A Wollheim, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Rheumatology|November 3, 2011
Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factorR Hesselstrand, A Scheja, D M Wuttge
Scandinavian Journal of Rheumatology|January 1, 1992
Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosisA Scheja, A Akesson, K Hørslev-Petersen
Scandinavian Journal of Rheumatology|December 20, 2007
Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experienceM Wildt, R Hesselstrand, A Akesson, et al.
Annals of the Rheumatic Diseases|June 15, 2004
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosisA Akesson, R Hesselstrand, A Scheja, et al.
Rheumatology (Oxford, England)|December 14, 2007
High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early diseaseR Hesselstrand, A Scheja, M Wildt, et al.
Acta Dermato-Venereologica|March 1, 1996
Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosisJ Wallengren, A Akesson, A Scheja, et al.
Clinical and Experimental Rheumatology|May 26, 1999
Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysisM Wildt, R Hesselstrand, A Scheja, et al.
Clinical and Experimental Rheumatology|January 1, 1985
Inhibition of in vivo leucocyte migration by NSAIDsA Scheja, A Forsgren, L Marsal, et al.
Scandinavian Journal of Rheumatology|September 23, 2011
Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestationsA Scheja, M Wildt, D M Wuttge, et al.
British Journal of Rheumatology|January 1, 1993
Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse diseaseA Scheja, G Hellmer, F A Wollheim, et al.
Pageof 5